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Abstract
Many different kinds of cells have been studied for transplantation in experimental animals 
including rats with spinal cord injury. This short review focused on adult somatic and 
umbilical cord cells to be used for therapy of spinal cord injury. Adult somatic cells have no 
inherent ethical problems in using for clinical application. Embryonic stem (ES) cells, 
neural stem cells, and induced pluripotent stem (iPS) cells were excluded. Bone marrow 
stromal cells and olfactory ensheathing cells have already been used clinically for 
transplantation to patients with spinal cord injury. Other cells dealt with in this review 
include dental pulp-derived, skin-derived, adipose-derived, and umbilical cord-derived stem 
cells, Muse cells, and choroid plexus epithelial cells.
Introduction
 This short review focused on somatic and um-
bilical stem cell transplantation therapy for spinal 
cord injury (SCI). Adult somatic and umbilical 
stem cells have no inherent ethical problems. 
Some of them have already been applied for clini-
cal use in patients with SCI, and others have the 
potential for clinical application in the near future. 
Embryonic stem (ES) cells and neural stem cells 
were extensively studied in previous decades. 
However, these cells were derived from embryon-
ic cells or neural tissues of neo- or prenatal ani-
mals, possibly leading to ethical problems with 
their clinical application. Cell transplantation 
studies aiming at the repair and regeneration of 
host tissues are of significance only when the cells 
being studied are clinically applicable. This re-
view focuses on the transplantation of cells that 
have no ethical or biological problems in clinical 
application. Induced pluripotent stem (iPS) cells 
have been studied as sources for cells of various
organs and tissues in regenerative medicine. 
However, iPS cells have not been used as yet for 
clinical treatment. 
 Here, studies on treatment for SCI by the trans-
plantation of cells listed as follows were  reviewed  : 
 I. Bone marrow stromal cell 
 2. Olfactory ensheathing cell 
 3. Dental pulp-derived stem cell 
 4. Skin-derived stem cell 
 5. Adipose-derived stem cell 
 6. Muse cell 
 7. Umbilical cord blood stem cell 
 8. Umbilical cord mesenchymal stem cell 
 9. Choroid plexus epithelial cell
1. Bone marrow stromal cell
 Bone marrow stromal cells (BMSCs) are bone 
marrow-derived, adherent cells in culture. They 
are called bone marrow-derived mononuclear 
cells (BMMCs) before culture. BMSCs and 
BMMCs contain a small number of stem  cells_
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BMSCs have been extensively studied. Please 
refer to our recent study (Nakano et al., 2013) to 
read about the current trends in BMSC transplan-
tation for SCI. Here, we would like to explain 
about BMSC transplantation based mainly on our 
own studies. BMSCs can be used for autologous 
transplantation. The transplantation of BMSCs is 
safe, with no ethical problems. The efficacy of 
BMSC transplantation for SCI has been estab-
lished. The clinical application of BMSCs by our 
group is presently in Phase  I/II. 
 BMSCs were transplanted via the cerebrospi-
nal fluid (CSF) or directly into lesions of the spinal 
cord in our transplantation studies. The basic 
findings concerning spinal cord repair and locomo-
tor recovery were compatible between the two 
transplantation techniques. 
 Before BMSC transplantation, the spinal cord of 
rats was crush-injured at the Th8-9 level by 
dropping a metal rod weighing 10 g from a height 
of 7.5 cm. 
 For acute SCI, BMSCs were transplanted via 
the CSF immediately after injury (Wu et al., 2003; 
Ohta et al., 2004). We examined cavity formation 
and the survival of axons in the host spinal cord 
lesion, and the BBB scores evaluating locomotor 
improvement. A small number of transplanted 
cells survived within the lesion, or on the surface 
of the spinal cord. However, they disappeared 
from the spinal cord at least 3 weeks after trans-
plantation. Cavity formation was reduced, and 
axonal outgrowth in the spinal cord was promoted 
in BMSC transplantation. BBB scores were 10-14 
in the BMSC-transplanted rats, and 5-10 in the 
control rats. This study was the first to demon-
strate the effects of BMSC transplantation via the 
CSF. From the finding that transplanted BMSCs 
disappeared from the spinal cord within 2-3 
weeks after transplantation, we hypothesized that 
BMSCs had effects not by integrating into host 
tissue, but by secreting some molecules into the 
CSF. There was no finding suggesting that 
BMSCs serve as a scaffold for the outgrowth of re-
generating axons. It is suggested that mesen-
chymal BMSCs are not integrated into the 
nervous tissue. 
 Next, we examined the effect of BMSC trans-
plantation on sub-acute SCI in rats (Ide et al. 
2010). BMSCs were injected directly into the spi-
nal cord lesion. Cell transplantation started 2 
weeks after spinal cord injury (sub-acute phase). 
Although engrafted BMSCs did not survive for 
longer than 2 weeks after transplantation, BMSC 
transplantation was effective. It was notable that 
numerous regenerating axons extended in
astrocyte-devoid areas in the lesion. Astrocyte-
devoid areas are filled with tissues including 
axons, Schwann cells, and vessels. It appeared 
that astrocytes did not invade or spread into such 
connective-like tissues occupied with extracellu-
lar matrices. Axons were surrounded by 
Schwann cells, a finding indicating that regener-
ating axons are peripheral nerves in the normal 
state. Cavity formation was markedly reduced in 
the BMSC-transplanted spinal cord. BBB scores 
were approximately 10 points in rats with BMSC 
transplantation, and below 6 points in the control 
at 4 and 8 weeks after transplantation. These 
results show that the transplantation of BMSCs 
into lesions of subacute SCI promoted tissue 
repair, axonal regeneration, and locomotor im-
provement of rats. 
 Recently, we examined the effect of three 
injections of BMSCs on subacute and chronic 
spinal cord injury (Nakano et al. 2013). BMSCs 
were injected via the CSF (through the 4th 
ventricle) 1, 2, and 4 weeks after SCI. BMSCs 
were injected three times weekly for three weeks. 
In this study, extensive axonal outgrowth was 
observed throughout the astrocyte-devoid areas 
(Figs. 1, 2). Axons extended throughout the 
length of the astrocyte-devoid areas and further 
extended into the host spinal cord tissue. Regen-
erating axons showed no findings suggesting the 
blockade of extension at the border of the lesion. 
BBB scores were 9-11 points in cell transplan-
tation groups, and 3-6 points in the control. We 
also found in this study that the CSF of rats that 
had been injected with BMSCs 2 days before 
harvesting had an effect on neuronal survival and 
neurite extension in vitro. 
 Based on these results, we examined the effect 
of BMSCs on clinical application. Firstly, we 
began clinical application in 5 patients in Kansai 
Medical University (Saito et al. 2012). Next, we 
performed the transplantation of BMMCs into 10 
patients with SCI in Kitano Hospital (Suzuki et al. 
2014). A basic study on the clinical application of 
BMMCs was published several years ago 
(Yoshihara et al. 2007). BMSCs and BMMCs 
have an advantage in that they can be transplan-
ted autologously. So far, there have been no 
adverse effects reported on the clinical usage of 
BMSC or BMMCs.
2. Olfactory ensheathing cell
 Olfactory ensheathing cells (OECs) are a type of 
Schwann cell associated with olfactory nerves 
extending from the olfactory epithelium to olfacto-
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Figure 1  Spinal cord of a BMSC-transplanted rat. 2-w post-
injury. Immunostaining for axons (red) and astrocytes (green). 
Transverse section. This rat had received BMSC injections 
starting at 2 weeks after contusion injury and was fixed 4 
weeks following the initial cell injection. BBB points were 3 
before BMSC injection and 9 at fixation. 
The panels (A), (B), and (C) show the cross sections of the 
spinal cord 1-mm rostral to the epicenter, epicenter of the 
lesion, and 1-mm caudal to the epicenter, respectively. The 
spinal cord at the epicenter (B) has, on the right margin of the 
spinal cord, a part of the white matter (shown in green) remain-
ing after injury, with numerous axons extending in the central 
area of the lesion. A part of the epicenter (* ) in (B) is enlarged 
in (D), showing numerous axons and a small number of 
astrocytes remaining on the margin of the spinal cord. Scale: 1 
mm for (A), (B), and  (C); 125  ,um for  (D). From Nakano et al. 
PLoS One (2013)
ry bulb. Olfactory cells are continuously supplied 
from basal cells of the olfactory epithelium: basal 
cells develop into olfactory cells, which, as neu-
rons in nature, project regenerating axons 
through OECs to the olfactory bulb in adults. 
OECs surround bundles of axons in the same 
fashion as unmyelinated nerves. OECs guide 
those regenerating axons to enter the olfactory 
bulb in adults. OECs are characterized by this 
unique property. 
 Schwann cells in peripheral nerves have no 
such property; regenerating axons' growth is 
blocked at the transition from the peripheral to 
central nervous system, for example, regenerat-
ing sensory axons' growth from the periphery is 
interrupted at the entry zone of the dorsal root. 
OECs transplanted into the injured spinal cord are 
considered to promote outgrowth of regenerating 
nerves through the lesion into the host tissue in
Figure 2 Electron microscopy of regenerating nerve fibers 
These micrographs were obtained from the spinal cord 
epicenter of the rat that had received BMSC transplantations 
starting at 4 weeks after contusion injury and was fixed 4 
weeks following the initial cell injection (4-w post-injury). BBB 
points were 4 before cell injection and 10 at fixation. 
(A) Myelinated nerve fibers are grouped in a small fascicle, which is 
   surrounded by a clear, cell-free space. Scale: 5  gm 
(B) Part of the nerve fascicle is enlarged. There are thick-myelinated 
  (M) and thin-myelinated (m) axons. The former issurrounded by a 
  Schwann cell  (S), and the latter is associated with a thin Schwann 
  cell cytoplasm, the basal lamina of which is clearly seen (arrow). An 
  unmyelinated fiber (a) is also seen near these myelinated axons. 
  These nerve fibers are located in the space, through which collagen 
  fibrils (C) are distributed, partly in association with Schwann cells. 
  Scale: 5  gm. From Nakano et  al. PLoS One (2013)
the spinal cord. 
 The autologous transplantation of OECs into 
patients with SCI is now under clinical trial. 
 The experimental transplantation of OECs was 
first conducted in 1994 (Ramon-Cueto and Nieto-
Sampedro, 1994). They purified OECs from the 
olfactory bulb, and implanted them into the spinal 
cord of rats with rhizotomy of the dorsal root at 
 T10. This study demonstrated that dorsal root 
axons extended through the PNS-CNS border into 
the spinal cord. This finding is important, as ex-
plained above. Since then, many studies have 
been conducted to examine the effectiveness of
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OECs for  SCI; a large number of studies reported 
the effective transplantation of OECs for SCI, 
while others presented unsupportive findings. 
Effective transplantation studies claim that OECs 
support the outgrowth of regenerating axons, and 
form a myelin sheath around naked axons. It 
appears that OECs do not migrate within the 
spinal cord after transplantation. 
 Li et al. (1998) reported successful results on 
transplantation into spinal cord lesions. They cre-
ated unilateral electrolytic lesions of the cortico-
spinal tract at C1-2, and transplanted OECs 
obtained from the olfactory bulb. They showed 
that corticospinal axons traversed the lesion site 
and reentered the caudal spinal cord. Regener-
ating axons were wrapped by a peripheral myelin 
sheath. Furthermore, they showed improvement 
of the forelimb function in a well-controlled sys-
tem. 
 Lu et al. (2002) transplanted pieces of the lamina 
propria of the olfactory mucosa into a rat spinal 
cord, in which the spinal cord had been  completely 
transected at  Th10 4 weeks prior. The scar tis-
sue was removed to create a 3-4-mm gap before 
transplantation. Ten weeks later, the locomotor 
activity of rats had significantly improved. Sero-
tonergic axons regenerated and extended across 
the transplanted site to the host spinal cord tissue 
caudally. They concluded that the nasal olfactory 
lamina propria has the ability to promote spinal 
cord regeneration 4 weeks after complete tran-
section. 
 Steward et al. (2006) recreated the experiment 
by Lu et al. (2002). This study was part of the 
NIH  "Facilities of Research- Spinal Cord Injury" 
contract to support the independent replication of 
published studies. This replication study system 
has been established to formally examine whether 
the excellent results of clinically relevant studies 
can be replicated. 
 Steward et al. replicated the experiment by Lu 
et al. The hind limb motor function was esti-
mated using the BBB scale. There was no signifi-
cant recovery after olfactory lamina propria 
transplantation, and no significant difference be-
tween the OLP and RLP (respiratory lamina 
propria containing no olfactory ensheathing cells). 
Fluorogold, a neural tracer, was injected into the 
distal segment to retrogradely label proximally 
located neurons. There were no neurons labeled 
with Fluorogold in the rostral part of the spinal 
cord. Serotonergic axons were found within the 
transplants, but a few serotonergic axons were 
present in the sections caudal to the injury in 2 
animals that received OLP transplant and 1
animal that received RLP transplant. 
 They concluded that, although OLP transplant 
may stimulate regeneration under some circum-
stances, the effect is not so robust. Similarly, 
Pearse et al. (2006) reported negative results. 
They transplanted purified olfactory ensheathing 
cells obtained from the olfactory bulb into the rat 
spinal cord at Th8 with moderate contusion inju-
ry. The results of their study were as follows: 
poor survival and no migration of OECs, and no 
axonal regeneration into the injury site. No major 
locomotor improvement was seen. 
 The effectiveness of the transplantation of 
OECs has been controversial. The survival, mi-
gration, and promotion of axonal regeneration of 
OECs after transplantation are major topics of 
debate. Myelination by transplanted OECs is an-
other major problem to be addressed. Axons seen 
in the spinal cord lesion are usually myelinated by 
Schwann cells. In OEC transplantation experi-
ments, it has yet to be determined whether such 
Schwann cells are derived from OECs or from 
other sources, such as nearby spinal root fibers. 
 In the study comparing the effects of OECs and 
BMSCs on spinal cord injury, both OECs and 
BMSCs disappeared from the spinal cord 2 weeks 
after transplantation, but provide tissue protec-
tion even in delayed transplantation. BMSCs im-
proved the locomotor function. BMSCs seem to 
be a more favorable option than OECs for SCI 
treatment (Torres-Espin et al. 2014). 
 OECs have the ability to interact with astro-
cytes, remyelinate axons, and contribute to angio-
genesis. Since they are able to interact with 
astrocytes, OECs can interact with scar tissue 
cells in the spinal cord (Franssen et al. 2007). 
This is an important difference from Schwann 
cells. Schwann cells and astrocytes are not able to 
be in direct contact with each other, because basal 
laminae are formed on both types of cell. 
 Raisman (2007) reported that grafted OECs 
encouraged the growth of cut nerve fibers, and 
that grafted cells adopt an elongated shape and 
align to form a bridge between the ends of the cut 
fiber tract. The regenerating nerve fibers enter 
the graft and cross the graft to re-enter the host 
spinal cord.
Clinical application 
 In a preclinical experiment, OECs from a single 
monkey olfactory bulb were cultured for 3 weeks, 
providing a sufficient number of OECs for auto-
graft transplantation, indicating that human olfac-
tory bulbs are reliable sources of OECs for cell 
transplantation (Rubio et al. 2008). Iwatsuki (2011)
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reported experimental and clinical studies of 
OECs. Tabakow et al. (2014) conducted OEC 
transplantation for patients with complete SCI at 
the thoracic level. OECs were grafted into the 
lesions of the spinal cord. There were no adverse 
findings. Neurological improvement was ob-
served in transplant patients. Two patients im-
proved from ASIA A to ASIA B and C. The third 
patient, even though remained ASIA A, showed 
improved motor and sensory functions of the 
spinal cord segments below the level of the injury.
3. Dental pulp-derived stem cells
 The dental pulp consists primarily of odonto-
blasts, fibroblasts, and nerves. Odontoblasts are 
arranged beneath the dentin, being involved in the 
production of tooth dentin. There are many 
capillaries with and around the dental pulp. In 
vitro experiments have shown that dental pulp 
cells differentiate into osteoblast, chondrocytes, 
and adipocytes (Gronthos et al. 2002; Balic et al. 
2010). In addition, dental pulp cells have the 
capacity to differentiate into neurons (markers: 
MAP2, neurofilament, and  , III-tubulin), astrocytes 
(marker: GFAP), and oligodendrocytes (marker: 
CNPase). Neurospheres are produced on dental 
pulp cell culture. 
 Dental pulp-derived stem cells (DPSCs) produce 
neurospheres on non-adhesion culture in rats 
(Takayasu et al. 2006; Sasaki et al. 2008) and 
humans (Govindasamy et al. 2010; Arthur et al. 
2008). DPSCs were first studied on transplanta-
tion in rats with SCI in 2012. Sakai et al. (2012) 
isolated and digested dental pulp cells from 
human dental pulp tissues to obtain single cell sus-
pensions. From these cell suspensions, DPSCs 
with mesenchymal stem cell markers such as 
 CD90, CD73, and  CD105 were separated and har-
vested by flow cytometry. Cells with endothelial/ 
hematopoietic markers such as CD34, CD45, 
CD11b/c, and HLA-DR were excluded. The rat 
spinal cord was completely transected with a sur-
gical blade at the Th9-11 level, and DPSCs were 
transplanted at the site 2 mm from the lesion in 
the rostral and caudal stump using a Hamilton 
syringe. In addition, DPSCs in fibrin glue were 
implanted into the transection gap to fill the lesion 
in the severed spinal cord. Rats were given cyclo-
sporine every day after surgery to prevent immu-
norejection of the transplanted DPSCs. There 
was marked locomotor ecovery in cell-transplan-
ted rats. DPSCs regenerated the transected 
corticospinal tract and raphespinal serotonergic 
axons. In vitro, conditioned medium of cultured
DPSCs promoted neurite extension activity under 
the severe condition of CSPG (chondroitin sulfate 
proteoglycan) or MAG (myelin-associated glyco-
protein) -mediated neurite growth inhibition. In 
this study, the authors emphasized that DPSCs 
exhibit three major neuroregenerative activities. 
Firstly, they inhibit the SCI-induced apoptosis of 
neurons, astrocytes, and oligodendrocytes. Sec-
ondly, they promote the regeneration of transect-
ed axons by directly inhibiting multiple axon 
growth inhibitors, including CSPG and MAG, via 
paracrine mechanisms. Thirdly, they differenti-
ate into oligodendrocytes in the severed spinal 
cord. The differentiation of DPSCs into neurons 
has not been identified in the spinal cord. 
 From these results, they concluded that DPSCs 
may provide therapeutic benefits for treating SCI 
through both cell-autonomous and paracrine neu-
roregenerative activities. Sugiyama et al. (2011) 
suggest that the recovery effects of DPSC trans-
plantation are mediated through the release of 
trophic factors from DPSCs. In line with this, 
Arthur et al. (2009) suggest the release of CXCL12 
chemokine from transplanted DPSCs, based on 
the finding that axons grow toward DPSCs 
implanted into the hindbrain of chicken embryos. 
Young et al. (2013) reviewed the potential roles of 
DPSCs in CNS regeneration and repair.
4. Skin-derived stem (precursor) cells
 Keratinocytes of the epidermis are continu-
ously supplied from the basal layer where new 
epidermal cells are produced by the mitosis of 
basal cells in adults. In addition, a hair follicle, 
involving the anagen-catagen cycle of the hair 
shaft is a site of active cell proliferation. The hair 
follicle has two sites with an abundance of imma-
ture cells: the dermal papilla at the bottom of the 
hair follicle, and hair bulge situated at the level of 
the sebaceous gland. 
 Hunt et al. (2008) demonstrated the presence of 
stem cells in the dermal papillae of adult skin. On 
development, skin-derived stem cells are readily 
obtained from the human neonatal fore skin. This 
means that stem cells are not restricted to hair 
follicles, but distributed throughout the skin dur-
ing development and growth. However, stem 
cells become limited to hair follicles in adults. 
Skin-derived stem cells are of neural crest  ori-
gin. Mice in which neural crest cells with the 
Wnt-1 gene are genetically engineered (Wntl-
Cre/R26R) to express  /3-galactosidase, were used 
for the visualization of neural crest cells.  Der-
mal papillae show an intense reaction for  ,8-
49
AINO JOURNAL, Vol. 12, 2013
galactosidase, indicating that neural crest cells 
reside in the dermal papillae. Some neural crest 
cells are found at other sites of both pelage and 
whisker hair follicles. Dermal papillae are en-
riched with sphere-forming cells. Cell spheres 
(papillasheres) are formed from dissociated der-
mal papilla cells in floating culture. Papilla-
spheres contain neural crest transcription factors 
such as Pax3 and Slug. Immunohistochemistry 
demonstrated that papillaspheres are composed 
of nestin  + and fibronection  +  •immunoreactive 
cells. 
 Papillaspheres generate neuronal cells by treat-
ment with neural differentiation medium contain-
ing neurotrophic factors (NT3, BDNF, and NGF), 
bFGF, and retinoic acid. Treatment with 
forskolin and neuregulin produced Schwann cells. 
 Papillaspheres can be generated from human 
facial skin dermal papillae. 
 Human papillaspheres differentiate into neu-
ronal and Schwann cells. For neuronal differenti-
ation, papillaspheres are cultured in the medium 
containing neurotrophic factors and retinoic acid, 
as in the case of rat papillapheres. Human papilla-
spheres also produce Schwann cells in medium 
containing forskolin and neuroregulin. 
 Liu et al. (2011) showed that bulge areas of the 
mouse vibrissal follicle contain nestin-expressing 
cells. Cell spheres are formed from both bulges 
and dermal papillae of mouse vibrissal hair  folli-
cles. However, cells from the bulge showed 
higher sphere-forming efficiency than those from 
the dermal papillae. These nestin-expressing 
cells differentiate into  Tujl- (neuronal cell) or 
GFAP-expressing (astrocyte) cells in medium 
lacking bFGF and EGF. 
 In an experiment in which spheres plus 
Gelfoam were transplanted into the spinal cords of 
nude mice, nestin-expressing sphere cells sur-
vived for over 100 days post-surgery. Cells from 
both the bulge area and dermal papillae migrated 
toward adjacent spinal cord segments. Axons 
grew into the transplant in the lesion. Seven to 8 
weeks after transplantation, transplants showed 
Tuj-1-, and GFAP-positive immunoreactions,  indi-
cating that some fractions of transplanted cells 
differentiated into neurons and astrocytes in the 
injured spinal cord. 
 Sieber-Blum et al. (2006) studied the effect of 
the transplantation of epidermal neural crest stem 
cells into a lesioned spinal cord. Epidermal neural 
crest cells are derived from the bulge area of a 
hair follicle. They demonstrated that bulge cells 
have the ability to differentiate into all major 
neural crest derivatives (Sieber-Blum et al. 2004).
Transplanted cells survived in the spinal cord le-
sion. They did not migrate or proliferate. There 
was no tumor formation. Many cells demon-
strated neuronal and glial markers in the spinal 
cord. Neuronal markers include   111  tubulin and 
GAD67 (glutamate decarboxylase 67), and glial 
markers include RIP and MBP (myelin basic 
protein). There were no GFAP-immunoreactive 
cells in the transplants. 
 These data indicate that cells derived from hair 
follicle bulges differentiate into neurons and oligo-
dendrocytes after transplantation into an injured 
spinal cord.
5. Adipose-derived stem (mesenchymal) cell
 Embryonic fetal stem cells (ES cells) and neural 
stem cells have drawn attention due to their high 
pluripotency and viability; however, they are asso-
ciated with ethical, regulatory, and availability 
concerns regarding clinical application. Adult 
adipose-derived stem cells have no ethical prob-
lem. Adipose-derived stem cells can be harvested 
from subcutaneous fat tissue, presenting no limita-
tion in terms of availability for clinical use. Bone 
marrow-derived stem cells are another type of 
mesenchymal stem cell. Mesenchymal stem cells 
are often called stromal cells (adipose-derived 
stromal cells or bone marrow-derived stromal 
cells). 
 Adipose tissue is a useful source of stem cells, 
since it is abundant in the subcutaneous zone, and 
can vigorously proliferate in vitro. Rhu et al. 
(2009) reported the isolation, culture, and charac-
terization of adipose stem cells, and their trans-
plantation into a canine model of acute SCI. The 
description below is based on their report: 
 Adipose tissue is collected from subcutaneous 
fat. Fat tissues are minced, digested with col-
lagenase, and centrifuged. Pellets of the cellular 
fraction are re-suspended, filtered through nylon 
mesh, and incubated in culture medium (DMEM) 
containing 10% fetal calf serum. The non-
adherent cells are removed, and cells adherent o 
the dish are further cultured in the medium sup-
plemented with epidermal growth factor (EGF), 
bovine pituitary extract, N-acetyl-L-cysteine, a-
scorbic acid, insulin, and hydrocortisone. These 
cells are characterized by CD  44(+), CD  90(+), 
 CD105  (+),  CD14  (—),  CD34  (—), and  CD45  (—). 
These adipose-derived stem cells can differentiate 
into adipocyte, chondrocyte, myocyte, osteoblast, 
and neural lineages. For neurogenic differentia-
tion, isolated adipose stem cells are preincubated 
in DMEM low-glucose medium supplemented
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with FBS and mercaptoethanol. After preincuba-
tion, the cells are incubated in neurogenic medium 
composed of DMEM supplemented with butylat-
ed hydroxyanisol and DMSO. For the differentia-
tion of other cell types, culture media specific for 
each cell type are used. A dog spinal cord was 
compression-injured at  Li by applying an epidural 
balloon catheter for  12 hours. A cell suspension 
containing  1  x  106 of cells in  150 of PBS was 
injected into the lesion at 3 sites (epicenter, and 
rostral and caudal borders of the lesion). Cells 
were transplanted  1 week after SCI. Dogs 
showed significant behavioral improvement at 
4-8 weeks after transplantation. Eight weeks 
after cell transplantation, immunohistochemistry 
showed that engrafted adipose-derived stem cells 
differentiated into astrocytes (marker: GFAP), 
neurons  (Tuj-1), and oligodendrocytes (MAB 
5540). This study indicates that engrafted cells 
that survived in the spinal cord and differentiated 
into neuronal cells, promoted the behavioral as 
well as histological recovery of injured spinal cord. 
On the other hand, cytoplasmic extracts of adi-
pose tissue stromal cells have effects on enhance-
ment of survival of cultured spinal cord-derived 
neural progenitor cells. 
 Arboleda et al.  (2011) studied the involvement 
of predifferentiated adipose-derived stromal cells 
(pASCs), comparing it with that of  naïve adipose-
derived stromal cells (ASCs). Adipose tissue was 
harvested from inguinal pads of GFP-transgenic 
SD rats. Cultured ASCs were plated in  10 cm2 
Petri dishes and induced to form spheres by 
replacing the proliferation medium with sphere-
induction medium consisting of DMEM/F12 
 ( +  Glutamax), B27 supplement, EGF, and bFGF. 
After 4 days of culture, the formed cell spheres 
were collected, plated on laminin-coated ishes, 
and then placed for 6 days in differentiation 
medium consisting of Neurobasal media supple-
mented with B27, NGF, and bFGF. 
 A total of 5  x  105 cells suspended in 5   l, of PBS 
were injected into the rostral, central, and caudal 
parts of the SCI lesion of Wistar rats. All rats 
were immunosuppressed by cyclosporine  injec-
tion throughout he experiment. 
 Both types of transplanted cell were detected in 
the host spinal cord at 8 weeks after transplanta-
tion. ASCs did not exhibit morphological changes 
from those seen in culture before transplantation. 
There was no finding suggesting interactions of 
transplanted cells with host neuronal cells. On 
the other hand, pASCs extensively migrated and 
showed interaction with axons. Although they re-
semble Schwann cells or oligodendrocytes associ-
ated with axons in appearance, electron micro-
scopy showed that they are perineurial cells sur-
rounding nerve fibers. pASCs or ASCs did not 
exhibit any neuronal markers suggesting differen-
tiation into neurons, astrocytes, or oligo-
dendrocytes. The fact that functional improve-
ments were comparable in both groups indicates 
that spinal cord repair is induced mainly through 
paracrine mechanisms. 
 Kingham et al.  (2014) stimulated ASCs in medi-
um containing  Q mercaptoethanol and retinoic 
acid for 24 hours, and then in medium containing 
neuregulin  1, bFGF, PDGF, and forskolin for 72 h. 
Stimulated ASCs secrete an increased amount of 
BDNF, GDNF, VEGF and  angiopoietin-1. 
 Both ASCs and pASCs have common CD 
antigens such as CD29, CD 90, CD  105, and  CD13. 
They are negative for CD  11b, CD19, CD 34,and 
CD 45 (Tapp et al. 2009). 
 Although adipose-derived stem cells have been 
reported to survive for several weeks after trans-
plantation, there has been no definite finding sug-
gesting the close interaction of engrafted adipose-
derived stem cells with the host spinal cord tissue. 
Several studies have indicated that ASCs have 
paracrine effects by secreting many trophic 
factors and cytokines. This characteristic is the 
same as that of BMSCs. It has been reported that 
ASCs secrete granulocyte macrophage-colony 
stimulating factor (GM-CSF), vascular endothelial 
growth factor (VEGF), hepatocyte growth factor 
(HGF), basic fibroblast growth factor (bFGF), 
transforming growth  factor -   (TGF- ), brain 
derived neurotrophic factor (BDNF), and insulin-
like growth  factor-1  (IGF-1). Wei et al. (2009) 
demonstrated that the conditioned medium of 
ASCs can protect against apoptosis induced by 
serum and potassium deprivation. This effect is 
mainly modulated by  IGF-1
6. Muse cells
 Muse (multilineage-differentiating stress-en-
during) cells are stem cells derived from mesen-
chymal populations such as dermal and bone 
marrow tissues (Kuroda et al. 2013). The first 
step is to culture mesenchymal populations from 
BMSCs or dermal fibroblasts. The second step is 
to isolate Muse cells by FACS. Muse cells are 
immunolabeled for stage-specific embryonic 
antigen-3 (SSEA-3), and isolated by FACS. These 
Muse cells form cell spheres in suspension culture. 
Spheres contains cells positive for alkaline phos-
phatase, and pluripotency markers, including 
Sox2, Oct3/4 and Nanog. These cells can undergo
 5'
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triploblastic differentiation (mesodermal, endo-
dermal, and ectodermal lineages). They actually 
differentiate into osteocytes, adipocytes, hepato-
cytes, and neural cells. It has been suggested that 
Muse cells are a primary source of induced 
pluripotent stem cell in human fibroblasts (Wakao 
et al. 2011). A transplantation study using Muse 
cells is now in progress.
7. Umbilical cord blood-derived stem cells
 It is known that human umbilical cord blood 
contains stem cells (UCBSCs). 
 Dasari et al. (2007) showed, based on study of a 
transplantation of UCBSCs into spinal cord-
injured rats, that UCBSCs transdifferentiated into 
neurons and oligodendrocytes. Remyelination oc-
curred on the transplantation of UCBSCs into 
shiverer mice (Veeravalli et al. 2011). The ques-
tion of whether the transplanted UCBSCs can 
differentiate into neuronal cells after transplanta-
tion is a critical problem. The findings of previous 
studies should be carefully re-examined in experi-
ments. On the other hand, UCBSCs have a neuro-
protective potential to protect against neuronal 
apoptosis in the injured spinal cord. UCBSCs 
have the ability to secrete many kinds of trophic 
factor such as  IL-10, GDNF, and VEGF. 
 The latest study (Cui et al. 2014) on the trans-
plantation of UBSCs into SCI rats reported the 
behavioral improvement of rats as estimated by 
BBB scores, and histological repair. In this study, 
1.0  X  107 human UBSCs were injected into spinal 
cord lesions, and behaviors of rats were observed 
1, 2, and 4 weeks after transplantation. BBB 
scores were higher in the cell-transplanted group 
than the control group. The authors stated that 
transplanted UBSCs differentiated into neurons 
and astrocytes in the spinal cord lesions based on 
immunohistochemical images of neurons and 
astrocytes within the spinal cord. However, these 
images do not provide evidence for the engrafted 
UBSCs differentiating into neuronal cells. It is 
probable that UBSCs have neurotrophic effects on 
the histological recovery of spinal cord injury. 
 Allogenic transplantation is a problem inherent 
to UCBSCs. This problem should be addressed 
before the clinical application of UCBSCs.
8. Umbilical cord matrix (Wharton's jelly) cells
 Umbilical cord mesenchymal stem cells 
(UMSCs) are obtained from the umbilical cord. 
Mesenchymal cells in the umbilical cord are con-
sidered developmentally primitive. Therefore, it
is reasonable to use these mesenchymal cells for 
transplantation into SCI. They cannot be used for 
autologous transplantation. 
 Yang et al. (2008) cultured mesenchymal stem 
cells from human Wharton's jelly, and trans-
planted then into the transection-injured spinal 
cord of rats. BBB scores were elevated. Axons 
regenerated into the lesion. Engrafted human 
UMSCs survived for 16 weeks. It has been 
reported that, in the CNS, allogeneic transplants 
can survive for a long time without immunosup-
pressants. In addition, they secrete neurotrophic 
factors such as NT-3 and bFGF.
9. Choroid plexus epithelial cells
 Choroid plexus epithelial cells (CPECs) are a 
type of glial cell, and they produce cerebrospinal 
fluid (CSF) at the blood-CSF barrier. Ide et al. 
(2001) first demonstrated that transplantation of 
minced choroid plexus tissues enhanced axonal 
outgrowth in the injured spinal cord of rats. 
Thereafter, CPECs have been studied from the 
point of view of cell transplantation. CPECs  con-
tain stem cells that differentiate to neurons, astro-
cytes, and oligodendrocytes (Kitada et al. 2001; 
Itokazu et al. 2006). Furthermore, the transplan-
tation of cultured CPECs via the CSF can rescue 
ischemic tissues in the rat brain to which blood 
supply from the middle cerebral artery has been 
interrupted (Matsumoto et al. 2010). The trans-
plantation of CPRCs through the CSF revealed 
that CPECs were not integrated into the host CNS 
after grafting, suggesting that CPECs secrete 
trophic factors effective for rescuing ischemic 
cerebral tissues. This has been supported by in 
vitro studies (Kimura et al. 2004; Chakrabortty 
et al. 2005; Watanabe et al. 2005). From this 
standpoint, viable CPECs are transplanted in an 
immunoprotected, encapsulated form directly 
into the site of injury (Skinner et al. 2006). 
Futhermore, CPECs have been proposed to 
prmote the neuroprotection in Huntington's dis-
ease (Emerich and Borlongan. 2009). It has been 
reported that cell proliferation and differentiation 
occurred in choroid plexus epithelium in response 
to stroke in rats (Li et al, 2002). CPECs undergo 
increases of NTF-a, and 70 in response 
to acute spinal cord injury in dogs (Moore and 
Oglesbee. 2012). These studies indicate that 
CPECs may play an important role in regulating 
and recovering normal functions following CNS 
injury.
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